MP15 Protocol for the administration and monitoring of Buccal Midazolam as rescue medication in prolonged epileptic seizures, status eplilepticus and seizure clustering for adults with learning disabilities


Category
Medicine management
Code
MP15
Issue No
1

Target Audience

Medical and Nursing staff within learning disability services

Purpose

The policy pulls together best available evidence for use of Midazolam as a rescue medication in epilepsy. Guidance on prescribing is provided and standards are set for the administering and monitoring of this drug. The aim of the policy is to ensure Midazolam is used effectively and in as safe a manner as possible so as to provide patients with consistent best practice.

Origin

Lead executive
Medical Director

Author and contact number
Consultant Psychiatrist
0151 653 9660


Policy dates & history

Implementation Date

30 April 2007

Review Date

30 April 2009

Approval Meeting

Medicines Management Group (MMG)

Ratification

Document Quality Group (DQG)

Download

MP15 Buccal Midazolam Issue 1 - GP71.pdf

0.13MB
Download Now
Text size A- A+
Contrast options